Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

A woman with severe angioedema improved significantly after treatment with rituximab.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Abrocitinib may effectively treat stubborn alopecia universalis.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Cepharanthine could be a strong antiviral against COVID-19.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Intralesional cidofovir may be a viable alternative treatment for SCC.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Murine cytomegalovirus does not cause alopecia areata in these mice.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.